0001164691-13-000023.txt : 20130214 0001164691-13-000023.hdr.sgml : 20130214 20130214123545 ACCESSION NUMBER: 0001164691-13-000023 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20130214 DATE AS OF CHANGE: 20130214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GenMark Diagnostics, Inc. CENTRAL INDEX KEY: 0001487371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 272053069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85510 FILM NUMBER: 13609471 BUSINESS ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 448-4300 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Alyeska Investment Group, L.P. CENTRAL INDEX KEY: 0001453072 IRS NUMBER: 261919051 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 77 WEST WACKER DRIVE STREET 2: 7TH FLOOR CITY: CHICAGO STATE: IL ZIP: 60601 BUSINESS PHONE: 312-899-7902 MAIL ADDRESS: STREET 1: 77 WEST WACKER DRIVE STREET 2: 7TH FLOOR CITY: CHICAGO STATE: IL ZIP: 60601 SC 13G/A 1 13GA123112.txt 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* GenMark Diagnostics, Inc. (GNMK) --------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------------- (Title of Class of Securities) 372309104 ---------------------------------------------------- (CUSIP Number) December 31, 2012 ------------------------------------------------------------------------------ (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). ------------------------------------------------------------------------------ CUSIP No. 372309104 SCHEDULE 13G ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Alyeska Investment Group, L.P. ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions): (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 578,793 EACH REPORTING ------------------------------------------- PERSON WITH (7) SOLE DISPOSITIVE POWER 0 ------------------------------------------- (8) SHARED DISPOSITIVE POWER 578,793 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 578,793 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.77% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) IA ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ CUSIP No. 372309104 SCHEDULE 13G ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Alyeska Investment Group, LLC ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions): (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION Delaware ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 578,793 EACH REPORTING ------------------------------------------- PERSON WITH (7) SOLE DISPOSITIVE POWER 0 ------------------------------------------- (8) SHARED DISPOSITIVE POWER 578,793 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 578,793 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.77% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) OO ------------------------------------------------------------------------------ ------------------------------------------------------------------------------- CUSIP No. 372309104 SCHEDULE 13G ------------------------------------------------------------------------------ (1) NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Anand Parekh ------------------------------------------------------------------------------ (2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions): (a) [ ] (b) [ ] ------------------------------------------------------------------------------ (3) SEC USE ONLY ------------------------------------------------------------------------------ (4) CITIZENSHIP OR PLACE OF ORGANIZATION United States of America ------------------------------------------------------------------------------ (5) SOLE VOTING POWER NUMBER OF 0 SHARES ------------------------------------------- BENEFICIALLY (6) SHARED VOTING POWER OWNED BY 578,793 EACH REPORTING ------------------------------------------- PERSON WITH (7) SOLE DISPOSITIVE POWER 0 ------------------------------------------- (8) SHARED DISPOSITIVE POWER 578,793 ------------------------------------------------------------------------------ (9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 578,793 ------------------------------------------------------------------------------ (10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] ------------------------------------------------------------------------------ (11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.77% ------------------------------------------------------------------------------ (12) TYPE OF REPORTING PERSON (See Instructions) IN ------------------------------------------------------------------------------ CUSIP NO. 372309104 SCHEDULE 13G Item 1(a). Name of Issuer: GenMark Diagnostics, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 5964 LA PLACE COURT CARLSBAD CA 92008 Item 2(a). Name of Persons Filing: (i) Alyeska Investment Group, L.P. (ii) Alyeska Investment Group, LLC (iii) Anand Parekh Item 2(b). Address of Principal Business Office or, if None, Residence: (i) 77 West Wacker Drive, 7th Floor Chicago, IL 60601 (ii) 77 West Wacker Drive, 7th Floor Chicago, IL 60601 (iii) 77 West Wacker Drive, 7th Floor Chicago, IL 60601 Item 2(c). Citizenship: (i) Alyeska Investment Group, L.P.- Delaware (ii) Alyeska Investment Group, LLC- Delaware (iii) Anand Parekh- United States of America Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 372309104 Item 3. If This Statement is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b), Check Whether the Person Filing is a: (a) Alyeska Investment Group, L.P., a limited partnership organized under the laws of the State of Delaware,is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940, as amended and is in accordance with 240.13d-1(b)(1)(ii)(E). (b)Alyeska Investment Group, LLC, a limited liability company organized under the laws of the State of Delaware, serves as the General Partner. (c) Anand Parekh is the Chief Executive Officer. Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Please refer to items 5-9 of the cover pages attached hereto (b) Please refer to item 11 of the cover pages attached hereto (c) Please refer to items 5-8 of the cover pages attached hereto Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: [X] Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Controlling Person. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Apllicable Item 9. Notice of Dissolution of Group Not Applicable Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP NO. 372309104 SCHEDULE 13G SIGNATURES After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2013 Alyeska Investment Group, L.P. By: /s/ Jason Bragg ------------------------------- Name: Jason Bragg Title: Chief Financial Officer and Chief Compliance Officer Alyeska Investment Group, LLC By: /s/ Jason Bragg ------------------------------- Name: Jason Bragg Title: Chief Financial Officer and Chief Compliance Officer Anand Parekh By: /s/ Anand Parekh ------------------------------- Name: Anand Parekh Individually CUSIP NO. 372309104 SCHEDULE 13G Exhibit A Agreement The undersigned agree that the statement to which this exhibit is appended is filed on behalf of each of them. Dated: February 14, 2013 Alyeska Investment Group, L.P. By: /s/ Jason Bragg ------------------------------- Name: Jason Bragg Title: Chief Financial Officer and Chief Compliance Officer Alyeska Investment Group, LLC By: /s/ Jason Bragg ------------------------------- Name: Jason Bragg Title: Chief Financial Officer and Chief Compliance Officer Anand Parekh By: /s/ Anand Parekh ------------------------------- Name: Anand Parekh Individually